+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Prefilled Syringes Market Size, Share & Trends Analysis Report by Type (Disposable, Reusable), by Material (Glass Syringes, Plastic Syringes), by Application (Anaphylaxis, Diabetes), End Use, by Region, and Segment Forecasts, 2022-2030

  • ID: 4599575
  • Report
  • April 2022
  • Region: Global
  • 110 Pages
  • Grand View Research

FEATURED COMPANIES

  • BD
  • Gerresheimer AG
  • Haselmeier AG
  • Nipro Corporation
  • Owen Mumford Ltd
  • Schott
The global prefilled syringes market size is anticipated to reach USD 50.83 billion by 2030, expanding at a CAGR of 11.95% from 2022 to 2030. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.



The current COVID-19 outbreak is expected to have a substantial impact on the industry. The pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment. According to American Pharmaceutical Review in December 2021, COVID-19 vaccines are being created at an unprecedented rate in response to the worldwide pandemic. COVID-19 vaccination doses totaled 7.3 billion by November 9, 2021, with approximately 30.3 million doses provided daily.

As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulting in increased demand for prefilled syringes. For instance, in March 2022, Schott announced further investments in its pharma sector, including expanding its capacity in Hungary for prefillable glass syringe production. The increased capacity is likely to benefit the global market and provide greater supply security for major pharmaceutical corporations and contract manufacturing firms. As a result, due to the outbreak of coronavirus infection in 2020, sales of prefilled syringes increased globally.

Furthermore, emergency syringes used to treat some of COVID-19's most significant side effects such as heart damage have historically been scarce. Despite the heightened demand during the outbreak, manufacturers provide various programs that identifies high-quality, protected supply bases for medications that are or could be added to the national drug scarcity list. For instance, in October 2019, Premier Inc. teamed up with Amphastar Pharmaceuticals, Inc. to provide phytonadione injection and emergency, pre-filled syringes of sulphate, dextrose, sodium bicarbonate, epinephrine, atropine, calcium chloride, and lidocaine to healthcare practitioners through its ProvideGx programme. These characteristics are projected to generate lucrative market growth prospects.

Prefilled Syringes Market Report Highlights

  • In terms of revenue, the disposable prefilled syringes segment accounted for the largest market share of 78.98% in 2021. This is owing to a high preference for patient safety, which has led to a rise in the use of disposable prefilled syringes in hospitals and home care settings.
  • The glass syringes segment dominated the market with around 53.27% of the revenue share in 2021, because most glass prefilled syringes may administer highly viscous drugs along with can be utilized across a wide range of therapeutic areas, such as vaccines, blood therapeutic proteins, and stimulants.
  • Diabetessegment captured the largest market share with around 53.75% in 2021. Increasing prevalence of diabetes globally along with the government initiatives.
  • The hospitals segment captured the largest market share with around 52.39% in 2021. The growth of this segment can mainly be attributed to increasing in the number of patients suffering from various chronic ailments and the consequent rise in surgical procedures.
  • Asia Pacific was the fastest-growing market for prefilled syringes with a growth rate of 12.96%, owing to the increasing patient population and rapid adoption of prefilled syringes in this region.
  • Prominent key players present in the prefilled syringes market are Gerresheimer AG, Schott Group, BD, Unilife Corporation, Nipro Medical Corporation, Owen Mumford, and Haselmeier AG.
Frequently Asked Questions about the Global Prefilled Syringes Market

What is the estimated value of the Global Prefilled Syringes Market?

The Global Prefilled Syringes Market was estimated to be valued at $20.6 Billion in 2022.

What is the growth rate of the Global Prefilled Syringes Market?

The growth rate of the Global Prefilled Syringes Market is 11.9%, with an estimated value of $50.8 Billion by 2030.

What is the forecasted size of the Global Prefilled Syringes Market?

The Global Prefilled Syringes Market is estimated to be worth $50.8 Billion by 2030.

Who are the key companies in the Global Prefilled Syringes Market?

Key companies in the Global Prefilled Syringes Market include BD, Gerresheimer AG, Schott, Stevanato Group, Unilife Corporation, Nipro Corporation, Haselmeier AG and Scandinavian Health Limited (Shl Group).
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BD
  • Gerresheimer AG
  • Haselmeier AG
  • Nipro Corporation
  • Owen Mumford Ltd
  • Schott

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 type
1.1.2 material
1.1.3 application
1.1.4 distribution channel
1.1.5 regional scope
1.1.6 estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 purchased database:
1.3.2 internal database
1.3.3 secondary sources
1.3.4 primary research
1.3.5 details of primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3. Prefilled Syringes Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List of Key End Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Steep rise in the development of biological therapies
3.5.1.2 High demand for the improved safety in injecTable
3.5.1.3 Growing adoption of self-care devices
3.5.1.4 Impact of COVID-19
3.5.2 Market Restraints Analysis
3.5.2.1 Limited production of plastic syringes
3.5.2.2 Negative impact on the environment due to pollution
3.6 Prefilled Syringes: Market Analysis Tools
3.6.1 Industry Analysis-Porter’s
3.6.2 Swot Analysis, by Pest
3.7 Impact of COVID-19 on Market
Chapter 4. Prefilled Syringes Market: Segment Analysis, by Type, 2017-2030 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Prefilled Syringes Market, by Type, 2017 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
4.5.1 Disposable Prefilled Syringes
4.5.1.1 Disposable prefilled syringes market, 2017-2030 (USD Million)
4.5.2 Reusable Prefilled Syringes
4.5.2.1 Reusable prefilled syringes market, 2017-2030 (USD Million)
Chapter 5. Prefilled Syringes Market: Segment Analysis, by Material, 2017-2030 (USD Million)
5.1 Definition and Scope
5.2 Material Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Prefilled Syringes Market, by Material, 2017 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
5.5.1 Glass Prefilled Syringes
5.5.1.1 Glass prefilled syringes market, 2017-2030 (USD Million)
5.5.2 Plastic Prefilled Syringes
5.5.2.1 Plastic prefilled syringes market, 2017-2030 (USD Million)
Chapter 6. Prefilled Syringes Market: Segment Analysis, by Application, 2017-2030 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Prefilled Syringes Market, by Application, 2017 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
6.5.1 Anaphylaxis
6.5.1.1 Anaphylaxis market, 2017-2030 (USD Million)
6.5.2 Rheumatoid Arthritis
6.5.2.1 Rheumatoid arthritis market, 2017-2030 (USD Million)
6.5.3 Diabetes
6.5.3.1 Diabetes Market, 2017-2030 (USD Million)
6.5.4 Others (Vaccine, Biotech Drugs)
6.5.4.1 Others (vaccine, biotech drugs) market, 2017-2030 (USD Million)
Chapter 7. Prefilled Syringes Market: Segment Analysis, by Distribution Channel, 2017-2030 (USD Million)
7.1 Definition and Scope
7.2 Distribution Channel Market Share Analysis, 2021 & 2030
7.3 Segment Dashboard
7.4 Global Prefilled Syringes Market, by Distribution Channel, 2017 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
7.5.1 Hospitals
7.5.1.1 Hospitals market, 2017-2030 (USD Million)
7.5.2 Mail Order Pharmacies
7.5.2.1 Mail order pharmacies market, 2017-2030 (USD Million)
7.5.3 Ambulatory Surgery Centers
7.5.3.1 Ambulatory surgery centers market, 2017-2030 (USD Million)
Chapter 8. Prefilled Syringes Market: Regional Market Analysis, by Type, by Material, by Application and by Distribution Channel, 2017-2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2021 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
8.6 North America
8.6.1 North America Prefilled Syringes Market, 2017-2030 (USD Million)
8.6.2 U.S.
8.6.2.1 U.S. prefilled syringes market, 2017-2030 (USD Million)
8.6.3 Canada
8.6.3.1 Canada prefilled syringes market, 2017-2030 (USD Million)
8.7 Europe
8.7.1 Europe Prefilled Syringes Market, 2017-2030 (USD Million)
8.7.2 U.K.
8.7.2.1 U.K. prefilled syringes market, 2017-2030 (USD Million)
8.7.3 Germany
8.7.3.1 Germany prefilled syringes market, 2017-2030 (USD Million)
8.7.4 France
8.7.4.1 France prefilled syringes market, 2017-2030 (USD Million)
8.7.5 Italy
8.7.5.1 Italy prefilled syringes market, 2017-2030 (USD Million)
8.7.6 Spain
8.7.6.1 Spain prefilled syringes market, 2017-2030 (USD Million)
8.8 Asia Pacific
8.8.1 Asia Pacific Prefilled Syringes Market, 2017-2030 (USD Million)
8.8.2 Japan
8.8.2.1 Japan prefilled syringes market, 2017-2030 (USD Million)
8.8.3 China
8.8.3.1 China prefilled syringes market, 2017-2030 (USD Million)
8.8.4 India
8.8.4.1 India prefilled syringes market, 2017-2030 (USD Million)
8.8.5 Australia
8.8.5.1 Australia prefilled syringes market, 2017-2030 (USD Million)
8.8.6 South Korea
8.8.6.1 South Korea prefilled syringes market, 2017-2030 (USD Million)
8.9 Latin America
8.9.1 Latin America Prefilled Syringes Market, 2017-2030 (USD Million)
8.9.2 Brazil
8.9.2.1 Brazil prefilled syringes market, 2017-2030 (USD Million)
8.9.3 Mexico
8.9.3.1 Mexico prefilled syringes market, 2017-2030 (USD Million)
8.9.4 Argentina
8.9.4.1 Argentina prefilled syringes market, 2017-2030 (USD Million)
8.9.5 Colombia
8.9.5.1 Colombia prefilled syringes market, 2017-2030 (USD Million)
8.10 MEA
8.10.1 MEA Prefilled Syringes Market, 2017-2030 (USD Million)
8.10.2 South Africa
8.10.2.1 South Africa prefilled syringes market, 2017-2030 (USD Million)
8.10.3 Saudi Arabia
8.10.3.1 Saudi Arabia prefilled syringes market, 2017-2030 (USD Million)
8.10.4 UAE
8.10.4.1 UAE prefilled syringes market, 2017-2030 (USD Million)
Chapter 9. Prefilled Syringes Market-Competitive Analysis
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 Key Company Market Share Analysis, 2021
9.3.2 Major Deals and Strategic Alliances
9.3.2.1 New Product Launch
9.3.2.2 Expansion
9.3.2.3 Acquistion
9.3.3 Market Entry Strategies
9.4 Company Profiles
9.4.1 BD
9.4.1.1 Company overview
9.4.1.2 Financial Performance
9.4.1.3 Product benchmarking
9.4.1.4 Strategic initiatives
9.4.2 Gerresheimer AG
9.4.2.1 Company overview
9.4.2.2 Financial Performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic initiatives
9.4.3 SCHOTT
9.4.3.1 Company overview
9.4.3.2 Financial performance
9.4.3.3 Product benchmarking
9.4.3.4 Strategic initiatives
9.4.4 Stevanato Group
9.4.4.1 Company overview
9.4.4.2 Product benchmarking
9.4.4.3 Strategic initiatives
9.4.5 Unilife Corporation
9.4.5.1 Company overview
9.4.5.2 Financial performance
9.4.5.3 Product benchmarking
9.4.5.4 Strategic initiatives
9.4.6 Nipro Corporation
9.4.6.1 Company overview
9.4.6.2 Financial performance
9.4.6.3 Product benchmarking
9.4.6.4 Strategic initiatives
9.4.7 Haselmeier AG
9.4.7.1 Company overview
9.4.7.2 Financial performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic initiatives
9.4.8 Owen Mumford Ltd
9.4.8.1 Company overview
9.4.8.2 Product benchmarking
9.4.8.3 Strategic initiatives
9.4.9 Scandinavian Health Limited (SHL Group)
9.4.9.1 Company overview
9.4.9.2 Product benchmarking
9.4.9.3 Strategic initiatives
Note: Product cover images may vary from those shown
  • BD
  • Gerresheimer AG
  • Schott
  • Stevanato Group
  • Unilife Corporation
  • Nipro Corporation
  • Haselmeier AG
  • Owen Mumford Ltd
  • Scandinavian Health Limited (Shl Group)
Note: Product cover images may vary from those shown

Loading
LOADING...